Organon & Co | OGN - PE Price to Earnings


Organon & Co reported 8.32 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Bristol-Myers Squibb 9.08 0.2 Mar/2026
Celltrion 58.97 8.86 Mar/2026
Cspc Pharmaceutical 24.4 1.13 Dec/2025
Deva Holding AS 6.55 2.01 Sep/2023
Dianthus Therapeutics 3.8 1.53 Sep/2024
Divis Laboratories Ltd 59.75 6.76 Mar/2026
Gilead Sciences 17.7 2.07 Mar/2026
Glaxosmithkline 15.09 3.43 Mar/2026
Kangmei Pharma 1.11K 2.04K Mar/2026
Knight Therapeutics 257.34 166.24 Dec/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Malin Corporation 11.81 0.72 Jun/2023
Merck 16.52 2.6 Mar/2026
Neuren Pharmaceuticals 72.14 59.86 Dec/2025
Novartis 21.36 3.57 Mar/2026
Organigram Holdings 12.01 222.99 Mar/2026
Organon & Co 8.32 4.57 Mar/2026
Ovoca Bio 1.83 3.29 Jun/2024
Pharma Mar 19.13 1.72 Mar/2026
Qiagen NV 20.54 0.1 Dec/2025
Sartorius 43.44 84.64 Mar/2026
Sino Biopharmaceutical 17.03 0.89 Jun/2025
Tilray 11.56 80.19 Sep/2025
Zealand Pharma A/S 5.13 0.16 Dec/2025